Cytokinetics | CYTK - Cost Of Sales

Stock Price
62.34
Daily Change
2.10 3.49%
Monthly
-4.71%
Yearly
45.79%
Q1 Forecast
61.24

Cytokinetics reported $112.55M in Cost of Sales for its fiscal quarter ending in June of 2025.





Cost Of Sales Change Date
Acadia Pharmaceuticals USD 21.65M 913K Sep/2025
Amgen USD 1.79B 128M Dec/2025
Bayer EUR 4.31B 57M Sep/2025
Biogen USD 810.1M 205.1M Sep/2025
Bristol-Myers Squibb USD 4.92B 657M Dec/2025
Cytokinetics USD 112.55M 12.71M Jun/2025
Eisai JPY 45.52B 2.92B Sep/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Exelixis USD 18.57M 896K Sep/2025
Geron USD 1.04M 147K Sep/2025
Halozyme Therapeutics USD 73M 8.88M Sep/2025
Ionis Pharmaceuticals USD 2.34M 1.81M Sep/2025
Ligand Pharmaceuticals USD 11.9M 733K Sep/2025
Merck USD 3.32B 531M Dec/2025
Novartis USD 3.54B 217M Sep/2025
Pfizer USD 6.29B 2.12B Dec/2025
Regeneron Pharmaceuticals USD 584.6M 63M Dec/2025
Roche Holding CHF 8.48B 4.61B Dec/2025
Sanofi EUR 4.29B 421M Dec/2025